Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms.
Saved in:
| Title: | Patients' perspectives on oral decitabine/cedazuridine for the treatment of myelodysplastic syndromes/neoplasms. |
|---|---|
| Authors: | Zeidan AM; Yale University and Yale Cancer Center, 333 Cedar Street, PO Box 208028, New Haven, CT 06520-8028, USA., Perepezko K; CorEvitas, LLC, Waltham, MA, USA., Salimi T; Taiho Oncology, Inc., Princeton, NJ, USA., Washington T; Taiho Oncology, Inc., Princeton, NJ, USA., Epstein RS; Epstein Health, LLC, Woodcliff Lake, NJ, USA. |
| Source: | Therapeutic advances in hematology [Ther Adv Hematol] 2024 Jul 30; Vol. 15, pp. 20406207241257313. Date of Electronic Publication: 2024 Jul 30 (Print Publication: 2024). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Sage Country of Publication: England NLM ID: 101549589 Publication Model: eCollection Cited Medium: Print ISSN: 2040-6207 (Print) Linking ISSN: 20406207 NLM ISO Abbreviation: Ther Adv Hematol Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2040-6207 |
|---|---|
| DOI: | 10.1177/20406207241257313 |
